Filter zurücksetzen
Stichworte
Leukämie ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

380 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

CALGB-10501 Diagnostic Blood/Bone Marrow Evaluation Form NCT00513747

- 20.09.21 - 1 Formular, 6 Itemgruppen, 30 Datenelemente, 1 Sprache
Itemgruppen: Header, Patient demographics, FOR INSTITUTIONS WITH ACCESS TO THE CALGB LABTRAK, Biopsy specimen, Contact information, Footer module
CALGB-10501 Diagnostic Blood/Bone Marrow Evaluation Form NCT00513747 Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3410554E-9E96-2D64-E044-0003BA3F9857

Eligibility DRKS00003838 NCT00701766 Leukemia, Myeloid, Acute - Eligibility

- 20.09.21 - 1 Formular, 2 Itemgruppen, 21 Datenelemente, 2 Sprachen
Itemgruppen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00701766

Eligibility DRKS00002025 NCT00606723 Acute Myeloid Leukemia (AML) - Eligibility

- 20.09.21 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 2 Sprachen
Itemgruppen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00606723

Eligibility DRKS00003742 NCT00632749 Leukemia, Myeloid, Acute - Eligibility

- 20.09.21 - 1 Formular, 2 Itemgruppen, 25 Datenelemente, 2 Sprachen
Itemgruppen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00632749

Eligibility NCT00560794 Acute Lymphoblastic Leukemia - Eligibility

- 20.09.21 - 1 Formular, 2 Itemgruppen, 24 Datenelemente, 2 Sprachen
Itemgruppen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00560794

E2905 On-Study Form NCT00843882

- 20.09.21 - 1 Formular, 5 Itemgruppen, 47 Datenelemente, 1 Sprache
Itemgruppen: Header, Data amendment, Patient Information, Prior Treatment, Comments
E2905 On-Study Form NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0EA9BECA-9DE5-1273-E044-0003BA3F9857

Registration Leukemia COG AALL08B1 NCT01142427

- 20.09.21 - 1 Formular, 9 Itemgruppen, 72 Datenelemente, 1 Sprache
Itemgruppen: Stratification, PATIENT CRITERIA, Consents I, Exclusion Criteria, Organ Function - Non Hematological, Organ Function - Hematological, Inclusion Criteria, Stratification II, CONSENT FOR RESEARCH STUDIES
COG AALL08B1 OPEN Registration Worksheet NCT01142427 Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=ADF3C25C-AD44-CFB2-E040-BB89AD4343C8

Leukemia DRKS00003845 NCT00651261 On-Study - CALGB: 10603 On-Study Form - 2719613v1.0 - CALGB: 10603 On-Study Form

- 20.09.21 - 1 Formular, 10 Itemgruppen, 46 Datenelemente, 1 Sprache
Itemgruppen: Header, Header Module, Patient Description, Leukemia Classification (WHO/FAB), Clinical Onset of AML, Extramedullary Disease Involvement, ORGAN INVOLVEMENT, Current Symptoms, Lab Data at Study Entry, Footer Module
CALGB: 10603 On-Study Form Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=437820BA-0A20-2BB7-E044-0003BA3F9857

E2905 Baseline Step 1 Disease Evaluation Form NCT00843882

- 20.09.21 - 1 Formular, 8 Itemgruppen, 56 Datenelemente, 1 Sprache
Itemgruppen: Header, Patient demographics, Data amendment, Pre-registration Hematology/chemistry, Leukemia Assessment, International Prognostic Score (IPSS), Baseline Abnormalities, Comments
E2905 Baseline Step 1 Disease Evaluation Form NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0EAB4E64-72BE-45B3-E044-0003BA3F9857

Initial assessment Leukemia AML-AZA in elderly patients NCT00915252

- 20.09.21 - 1 Formular, 10 Itemgruppen, 80 Datenelemente, 2 Sprachen
Itemgruppen: Patient data, Clinical findings, Comorbidities, Differential blood count, Clinical Chemistry, Knochenmarkuntersuchung, Zytologie, FAB-Klassifikation, Molekulargenetik, Unterschrift
A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML NCT00915252

Eligibility NCT00373373 Acute Myeloid Leukemia - Eligibility

- 20.09.21 - 1 Formular, 2 Itemgruppen, 28 Datenelemente, 2 Sprachen
Itemgruppen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00373373

2. Induction AML-AZA elderly patients NCT00915252

- 20.09.21 - 1 Formular, 21 Itemgruppen, 88 Datenelemente, 2 Sprachen
Itemgruppen: Patientendaten, Clinical finding, Differential blood count, Klinische Chemie, 5-Azacytidine, 5-Azacytidine - Dose no. 1, 5-Azacytidine - Dose no. 2, 5-Azacytidine - Dose no. 3, 5-Azacytidine - Dose no. 4, 5-Azacytidine - Dose no. 5, 5-Azacytidine dose reduction, Transfusions, Chemotherapy, Ara-C , Daunorubicin, G-CSF, Cytopenia duration, Leukopenia, Neutropenia, Thrombopenia, Unterschrift
2. Induktionstherapieblock EudraCT-Nr 2008-004583-40 Akute myeloische Leukmie(AML) AML alle auer FAB M3 (5-Azacytidin plus Standardtherapie bei älteren AML-Patienten Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) (AML-AZA) NCT00915252

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video